A detailed history of Richwood Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Richwood Investment Advisors, LLC holds 11,598 shares of BMY stock, worth $681,730. This represents 0.5% of its overall portfolio holdings.

Number of Shares
11,598
Previous 12,317 5.84%
Holding current value
$681,730
Previous $511,000 17.42%
% of portfolio
0.5%
Previous 0.45%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$39.66 - $51.75 $28,515 - $37,208
-719 Reduced 5.84%
11,598 $600,000
Q2 2024

Jul 26, 2024

SELL
$40.25 - $52.99 $20,286 - $26,706
-504 Reduced 3.93%
12,317 $511,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $93,513 - $106,025
-1,949 Reduced 13.2%
12,821 $695,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $23,561 - $28,115
-486 Reduced 3.19%
14,770 $757,000
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $7,815 - $8,738
-135 Reduced 0.88%
15,256 $885,000
Q2 2023

Jul 21, 2023

SELL
$63.71 - $70.74 $3,121 - $3,466
-49 Reduced 0.32%
15,391 $984,000
Q1 2023

Apr 19, 2023

SELL
$65.71 - $74.53 $1,379 - $1,565
-21 Reduced 0.14%
15,440 $1.07 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $14,106 - $16,704
206 Added 1.35%
15,461 $1.11 Million
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $11 - $6,915
-90 Reduced 0.59%
15,255 $1.09 Million
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $5,954 - $6,558
82 Added 0.54%
15,345 $1.18 Million
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $4,303 - $5,160
70 Added 0.46%
15,263 $1.12 Million
Q4 2021

Feb 17, 2022

BUY
$53.63 - $62.52 $814,800 - $949,866
15,193 New
15,193 $947,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Richwood Investment Advisors, LLC Portfolio

Follow Richwood Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richwood Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richwood Investment Advisors, LLC with notifications on news.